- https://doi.org/10.14800/ics.1197
The value of diagnostic model on COVID-19 by Comparing the Features between SARS-COV-2 and other viral infections
Translate Article 
With the expansion of 2019 novel coronavirus disease(COVID-19), large of suspected cases were reported. This essay compares the clinical features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and other viral infections among the suspected COVID-19 patients, and attempts to explore an ideal diagnostic model of COVID-19. 60 viral pneumonia patients from 86 suspected patients were enrolled and grouped into two: the COVID-19 group (19 cases) and other viral infections group (41 cases). Compare and analyze the blood test results, biochemical indicators and chest CT scan changes of patients. 60 patients were mainly young and middle-aged men, of which 60%were infected with influenza virus, and 31.6%were infected with SARS-COV-2 according to pathogenic distribution. And we found statistic differences among blood cell counts and blood biochemistry between the two groups. The COVID-19 patients' chest CT showed that the lung lesions were mainly bilateral nodule or appeared to be patchy and ground glass shadowed. While most of the lung lesions caused by other virus were mainly unilateral patchy shadow (P＜0.05). We found a new multi-marker PTG, which composed of platelet-to-neutrophil ratio(PNR), total bilirubin(TBIL) and ground-grass density, The area sunder curves(AUC)of PTG was 0.908, the sensitivity was 73.17%and the specificity was 94.44%. The ratio of blood RT to its sub-group and chest CT were considered as important reference in differential diagnosis. The PTG, with extremely high specificity and sensitivity in early differential diagnosis of COVID-19 and other viral pneumonia, had a significant clinical value.
- Research Article
22 - 10.31635/ccschem.020.202000322
- Jul 10, 2020
- CCS Chemistry
Coronavirus disease 2019 (COVID-19) is caused by a novel strain of coronavirus, designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has caused a global pandemic rapidly s...
- Discussion
- 3
- 10.1016/j.clinimag.2021.02.044
- Mar 26, 2021
- Clinical Imaging
Pneumocystis pneumonia: An important consideration when investigating artificial intelligence-based methods in the radiological diagnosis of COVID-19
- Discussion
- 7
- 10.1016/j.jinf.2022.06.021
- Jun 26, 2022
- The Journal of Infection
SNX27-mediated endocytic recycling of GLUT1 is suppressed by SARS-CoV-2 spike, possibly explaining neuromuscular disorders in patients with COVID-19
- Research Article
- 66
- 10.1111/ajt.16261
- Oct 2, 2020
- American Journal of Transplantation
Evidence of potent humoral immune activity in COVID-19-infected kidney transplant recipients.
- Front Matter
- 74
- 10.7326/m20-1382
- Apr 8, 2020
- Annals of Internal Medicine
This commentary discusses the findings of early studies that addressed the use of chest computed tomography for the detection of COVID-19. The authors urge caution in rushing science and overinterp...
- Research Article
- 24
- 10.1097/cm9.0000000000000899
- Jul 5, 2020
- Chinese Medical Journal
In December 2019, a novel coronavirus was identified in Wuhan City, Hubei Province, China and later the disease was named coronavirus disease 2019 (COVID-19). On March 11, 2020, the World Health Organization (WHO) officially announced that COVID-19 had reached global pandemic status. This article summarized the understanding of the etiology, pathogenesis, epidemiology, clinical characteristics, diagnosis, treatment, rehabilitation, and prevention and control measures of COVID-19 based on the available data and anti-epidemic experience in China.
- Research Article
- 21
- 10.1097/shk.0000000000001730
- Jan 20, 2021
- Shock (Augusta, Ga.)
COVID-19-related coagulopathy is a known complication of SARS-CoV-2 infection and can lead to intracranial hemorrhage (ICH), one of the most feared complications of extracorporeal membrane oxygenation (ECMO). We sought to evaluate the incidence and etiology of ICH in patients with COVID-19 requiring ECMO. Patients at two academic medical centers with COVID-19 who required venovenous-ECMO support for acute respiratory distress syndrome (ARDS) were evaluated retrospectively. During the study period, 33 patients required ECMO support; 16 (48.5%) were discharged alive, 13 died (39.4%), and 4 (12.1%) had ongoing care. Eleven patients had ICH (33.3%). All ICH events occurred in patients who received intravenous anticoagulation. The ICH group had higher C-reactive protein (P = 0.04), procalcitonin levels (P = 0.02), and IL-6 levels (P = 0.05), lower blood pH before and after ECMO (P < 0.01), and higher activated partial thromboplastin times throughout the hospital stay (P < 0.0001). ICH-free survival was lower in COVID-19 patients than in patients on ECMO for ARDS caused by other viruses (49% vs. 79%, P = 0.02). In conclusion, patients with COVID-19 can be successfully bridged to recovery using ECMO but may suffer higher rates of ICH compared to those with other viral respiratory infections.
- Research Article
- 24
- 10.1053/j.gastro.2021.09.009
- Sep 8, 2021
- Gastroenterology
Targeting the Gut Microbiota in Coronavirus Disease 2019: Hype or Hope?
- Research Article
- 247
- 10.1002/uog.22013
- Mar 20, 2020
- Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals.
- Research Article
- 37
- 10.1111/ajt.16082
- Jul 5, 2020
- American Journal of Transplantation
Strategies for liver transplantation during the SARS-CoV-2 outbreak: Preliminary experience from a single center in France.
- Discussion
- 3
- 10.1016/j.radonc.2020.07.006
- Jul 15, 2020
- Radiotherapy and Oncology
The use of simulation-CT’s as a coronavirus disease 2019 screening tool during the severe acute respiratory syndrome coronavirus 2 pandemic
- Research Article
- 13
- 10.1111/ajt.16572
- Apr 2, 2021
- American Journal of Transplantation
Multisystem inflammatory syndrome in children associated with SARS-CoV-2 in a solid organ transplant recipient.
- Discussion
- 1
- 10.1053/j.jvca.2020.08.041
- Aug 26, 2020
- Journal of Cardiothoracic and Vascular Anesthesia
Testing the Asymptomatic Pre-Surgical Population for Severe Acute Respiratory Syndrome Coronavirus 2
- Research Article
- 190
- 10.1016/s2665-9913(20)30420-3
- Jan 7, 2021
- The Lancet. Rheumatology
COVID-19 vasculitis and novel vasculitis mimics.
- Discussion
- 92
- 10.1016/j.jns.2020.116943
- May 23, 2020
- Journal of the Neurological Sciences
Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe Covid-19
